Investigation into modification of mass transfer kinetics by acrolein in a renal biochip

Toxicology in Vitro

Volumn 25, Issue 5, 2011, Pages 1123-1131

  Ramello, Clelia ^a   Paullier, Patrick ^a   Ould Dris, Aissa ^b   Monge, Matthieu ^c,d   Legallais, Cécile ^a   Leclerc, Eric ^a  

^a UNIVERSITÉ DE TECHNOLOGIE DE COMPIÈGNE   (France)

^b UNIVERSITÉ DE TECHNOLOGIE DE COMPIÈGNE   (France)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^d AMIENS UNIVERSITY HOSPITAL   (France)

Author keywords

Acrolein toxicity; Bioartificial kidney; Blood tissue barrier model; Drug permeability; Ifosfamide; PDMS; Renal clearance

Indexed keywords

ACROLEIN; CAFFEINE;

ANIMAL CELL; APICAL MEMBRANE; ARTICLE; BASOLATERAL MEMBRANE; BIOCHIP; BLOOD RENAL BARRIER; CONTROLLED STUDY; CYTOTOXICITY; DOG; IN VITRO STUDY; MEMBRANE PERMEABILITY; MEMBRANE RESISTANCE; MEMBRANE TRANSPORT; MOLECULAR WEIGHT; NEPHROTOXICITY; NONHUMAN; PERMEABILITY BARRIER; SENSITIVITY ANALYSIS; TOXICITY TESTING; TRANSPORT KINETICS;

ACROLEIN; ALBUMINS; ANIMALS; BIOARTIFICIAL ORGANS; BIOLOGICAL MARKERS; CAFFEINE; CELL LINE; CYCLOPHOSPHAMIDE; DIMETHYLPOLYSILOXANES; DOGS; IFOSFAMIDE; KIDNEY; KINETICS; MICROFLUIDIC ANALYTICAL TECHNIQUES; MODELS, BIOLOGICAL; PROTEIN ARRAY ANALYSIS; RENAL DIALYSIS; VITAMIN B 12;

EID: 79957949200     PISSN: 08872333     EISSN: 18793177     Source Type: Journal    
DOI: 10.1016/j.tiv.2011.03.017     Document Type: Article

References (32)

1. Ahluwalia A., Maggi C., Santicioli P., Lecci A., Giuliani S. Characterization of the capsaicin-sensitive component of cyclophosphamide-induced inflammation in the rat urinary bladder. Br. J. Pharmacol. 1994, 111:1017-1022.
2. Baudoin R., Corlu A., Griscom L., Legallais C., Leclerc E. Trends in the development of microfluidic cell biochips for in vitro hepatotoxicity. Toxicol. In Vitro 2007, 21:535-544.
3. Baudoin R., Griscom L., Monge M., Legallais C., Leclerc E. Development of a renal microchip for in vitro distal tubule models. Biotechnol. Prog. 2007, 23:1245-1253.
4. Bendayan M., Rasio E. Transport of insulin and albumin by the microvascular endothelium of the rete Mirabile. J. Cell Sci. 1996, 109:1857-1864.
5. 12 and folate homeostasis: characterization of receptors for tubular uptake of vitamins and carrier proteins. Am. J. Physiol. Renal. Physiol. 2006, 291:F22-F36.
6. Broadhead C.L., Walker D.H., Skinner R., Simmons N.L. Differential cytotoxicity of Ifosfamide and its metabolites in renal epithelial cell cultures. Toxicol. In Vitro 1998, 12:209-217.
7. Brock N., Stekar J., Pohl J., Niemeyer U., Scheffler G. Acrolein the causative factor of urotoxic side effect of cyclophosphamide, ifosfamide, trofosfamide ans sufosfamide. Drug Res. 1979, 29:659-661.
8. Chao P., Maguire T., Novik E., Cheng K.C., Yarmush M.L. Evaluation of a microfluidic based cell culture platform with primary human hepatocytes for the prediction of hepatic clearance in human. Biochem. Pharmacol. 2009, 78:625-632.
9. Drade W., Herdrick K., Varini M. Ifosfamide, pharmacology safety and therapeutic potential. Cancer Treat. Rev. 1985, 12:1-47.
10. Garberg P., Ball M., Borg N., Cecchelli R., Fenart L., Hurst R., Lindmark T., Mabonzo A., Nilsson J.E., Raub T., Stanimirovic D., Terasaki T., Oberg J., Osterberg T. In vitro models for the blood-brain barrier. Toxicol. In Vitro 2005, 19:299-334.
11. García N., Ramsey C., Knox F. Understanding the role of paracellular transport in the proximal tubule. News Physiol. Sci. 1998, 13:38-43.
12. Ho P., Zimmerman K., Wexler L., Blaney S., Jarosinski P., Izraeli S., Balis F. A prospective evaluation of ifosfamide related nephrotoxicity in children and young adults. Cancer 1995, 76:2557-2564.
13. Imura Y., Asano Y., Sato K., Yoshimura E. A microfluidic system to evaluate intestinal absorption. Anal. Sci. 2009, 25:1403-1407.
14. Jarad G., Miner J. Update on the glomerular filtration barrier. Curr. Opin. Nephrol. Hypertens. 2009, 18:226-232.
15. Kaazempur-Mofrad, M.R, Vacanti, J.P., Krebs, N.J., Borenstein, J.T., 2004. A MEMS based renal replacement system. In: Solid-State Sensor, Actuator and Microsystems, Workshop, South Carolina, June 6-10.
16. Kimura H., Yamamoto T., Sakai H., Sakai Y., Fujii T. An integrated microfluidic system for long-term perfusion culture and on-line monitoring of intestinal tissue models" Lab Chip 2008, 8:741-746.
17. Nakayama H., Kimura H., Komori K., Fujii T., Sakai Y. Development of a multi-compartment micro-cell culture device as a future on-chip human: fabrication of a three-compartment device and immobilization of rat mature adipocytes for the evaluation of chemical distributions. J. Rob. Mechatron. 2007, 19:544-549.
18. 12 and its use in measurement of glomerular filtration rate in man. J. Lab. Clin. Med. 1963, 63:480-491.
19. 12 in LLC-PK1 renal proximal tubule cells. J. Am. Soc. Nephrol. 2001, 12:1099-1106.
20. Ould Dris A., Paullier P., Griscom L., Legallais C., Leclerc E. Analysis of the mass transfers in an artificial kidney microchip. J. Membr. Sci. 2010, 352:116-125.
21. Mohrmann M., Ansorge S., Schmich U., Schonfeld B., Brandis M. Toxicity of ifosfamide, cyclophosphamide and their metabolites in renal tubular cells in culture. Pediatr. Nephrol. 1994, 8:157-163.
22. Parent R.A., Caravello H.E., Balmer M.F., et al. One-year toxicity of orally administered acrolein to the beagle dog. J. Appl. Toxicol 1992, 12:311-316.
23. Ramu K., Fraiser L., Mamiya B. Acrolein mercapturates: synthesis, characterization, and assessment of their role in the bladder toxicity of cyclophosphamide. Chem. Res. Toxicol. 1995, 8:515-524.
24. Russell-Jones, G., Alpers, D., 2002. vitamin b12 transporters membrane transporters as drug targets. Pharm. Biotechnol. 12, 493-520.
25. Schwerdt G., Gordjani N., Benesic A., Freudinger R., Wollny B., Antje K., Gekle M. Chloroacetaldehyde and acrolein induced death of human proximal tubule cells. Pediatr. Nephrol. 2006, 21:60-67.
26. Springate J., Taub M. Ifosfamide toxicity in cultured proximal renal tubule cells. Pediatr. Nephrol. 2007, 22:358-365.
27. Sung J.H., Kam C., Shuler M.J. A microfluidic device for a pharmacokinetic-pharmacodynamic (PK-PD) model on a chip. Lab. Chip. 2010, 10:446-455.
28. Toh Y.C., Lim T.C., Tai D., Xiao G., van Noort D., Yu H. A microfluidic 3D hepatocyte chip for drug toxicity testing. Lab. Chip 2009, 9:2026-2031.
29. Viravaidya K., Sin A., Shuler M.L. Development of a microscale cell culture analog to probe naphthalene toxicity. Biotechnol. Prog. 2004, 20:316-323.
30. Wang Q., Rager J., Weinstein K., Kardos P., Dobson G., Li J., Hidalgo I. Evaluation of the MDR-MDCK cell line as a permeability screen for blood-brain barrier. Int. J. Pharm. 2005, 288:349-359.
31. Yeon J., Park J. Drug permeability assay using microhole trapped cells in a microfluidic device. Anal. Chem. 2009, 81:1944-1951.
32. Zhang J., Tian Q., Chan S., Duan W., Zhou S. Insights into oxazaphosphorine resistance and possible approaches to its circumvention. Drug Resist. Updates 2005, 8:271-297.